The movement of cancer cells toward CXCL12 in metastatic sites is determined by the gain of CXCR4 expression and the loss of CXCL12 on the primary tumor at the same time, enabling movement of tumor cells, along with the CXCL12 gradient, toward the metastatic niche [66]. This evidence concerns the gene CXCR4 and cancer.